{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T16:06:02Z","timestamp":1786982762587,"version":"build-2736575974"},"reference-count":62,"publisher":"Springer Science and Business Media LLC","issue":"18","license":[{"start":{"date-parts":[[2015,11,24]],"date-time":"2015-11-24T00:00:00Z","timestamp":1448323200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Drugs"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1007\/s40265-015-0504-9","type":"journal-article","created":{"date-parts":[[2015,11,24]],"date-time":"2015-11-24T05:14:08Z","timestamp":1448342048000},"page":"2057-2063","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":24,"title":["The Challenges of Interstitial Cystitis: Current Status and Future Prospects"],"prefix":"10.1007","volume":"75","author":[{"given":"Samuel","family":"Belknap","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Blalock","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deborah","family":"Erickson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,11,24]]},"reference":[{"issue":"5","key":"504_CR1","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1016\/j.juro.2015.01.086","volume":"193","author":"PM Hanno","year":"2015","unstructured":"Hanno PM, Erickson D, Moldwin R, Faraday MM. Diagnosis and treatment of interstitial cystitis\/bladder pain syndrome: AUA guideline amendment. J Urol. 2015;193(5):1545\u201353.","journal-title":"J Urol."},{"issue":"1","key":"504_CR2","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.eururo.2007.09.019","volume":"53","author":"JP Merwe van de","year":"2008","unstructured":"van de Merwe JP, Nordling J, Bouchelouche P, Bouchelouche K, Cervigni M, Daha LK, Elneil S, Fall M, Hohlbrugger G, Irwin P, Mortensen S, van Ophoven A, Osborne JL, Peeker R, Richter B, Riedl C, Sairanen J, Tinzl M, Wyndaele JJ. Diagnostic criteria, classification, and nomenclature for painful bladder syndrome\/interstitial cystitis: an ESSIC proposal. Eur Urol. 2008;53(1):60\u20137.","journal-title":"Eur Urol."},{"issue":"1","key":"504_CR3","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1111\/j.1442-2042.2008.02208.x","volume":"16","author":"Y Homma","year":"2009","unstructured":"Homma Y, Ueda T, Ito T, Takei M, Tomoe H. Japanese guideline for diagnosis and treatment of interstitial cystitis. I Int J Urol. 2009;16(1):4\u201316.","journal-title":"I Int J Urol."},{"issue":"6 Suppl 1","key":"504_CR4","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/S0090-4295(01)01127-X","volume":"57","author":"SK Keay","year":"2001","unstructured":"Keay SK, Zhang CO, Shoenfelt J, Erickson DR, Whitmore K, Warren JW, Marvel R, Chai T. Sensitivity and specificity of antiproliferative factor, heparin-binding epidermal growth factor-like growth factor, and epidermal growth factor as urine markers for interstitial cystitis. Urology. 2001;57(6 Suppl 1):9\u201314.","journal-title":"Urology"},{"issue":"2","key":"504_CR5","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1111\/bju.12603","volume":"114","author":"CL Parsons","year":"2014","unstructured":"Parsons CL, Shaw T, Berecz Z, Su Y, Zupkas P, Argade S. Role of urinary cations in the aetiology of bladder symptoms and interstitial cystitis. BJU Int. 2014;114(2):286\u201393.","journal-title":"BJU Int."},{"key":"504_CR6","doi-asserted-by":"crossref","unstructured":"Rubio-Diaz DE, Pozza ME, Dimitrakov J, Gilleran JP, Guisti MM, Stella JL, Rodriguez-Saona LE, Buffington CA. A candidate serum biomarker for bladder pain syndrome\/interstitial cystitis. Analyst. 2009;134(6):1133\u20137.","DOI":"10.1039\/b901736d"},{"issue":"3","key":"504_CR7","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1016\/j.juro.2014.09.036","volume":"193","author":"JC Nickel","year":"2015","unstructured":"Nickel JC, Herschorn S, Whitmore KE, Forrest JB, Hu P, Friedman AJ, Baseman AS. Pentosan polysulfate sodium for treatment of interstitial cystitis\/bladder pain syndrome: insights from a randomized, double-blind, placebo controlled study. J Urol. 2015;193(3):857\u201362.","journal-title":"J Urol."},{"issue":"1","key":"504_CR8","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/S0090-4295(97)00110-6","volume":"50","author":"P Hwang","year":"1997","unstructured":"Hwang P, Auclair B, Beechinor D, Diment M, Einarson TR. Efficacy of pentosan polysulfate in the treatment of interstitial cystitis: a meta-analysis. Urology. 1997;50(1):39\u201343.","journal-title":"Urology"},{"issue":"2","key":"504_CR9","first-page":"7739","volume":"22","author":"CL Parsons","year":"2015","unstructured":"Parsons CL, Koziol JA, Proctor JG, Zupkas P, Argade S. Heparin and alkalinized lidocaine versus alkalinized lidocaine for treatment of interstitial cystitis symptoms. Can J Urol. 2015;22(2):7739\u201344.","journal-title":"Can J Urol."},{"key":"504_CR10","doi-asserted-by":"crossref","unstructured":"Hanno PM. Painful bladder syndrome (Interstitial Cystitis) and related disorers. In: Wein AJ, Kavoussi LR, Novick AC, Partin AW, Peters CA, editors. Campbell-Walsh Urology. 10th ed. Philadelphia; 2012. p. 470\u2013537.","DOI":"10.1016\/B978-1-4160-6911-9.00012-8"},{"issue":"2","key":"504_CR11","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1111\/j.1464-410X.2012.11635.x","volume":"111","author":"CL Chintea","year":"2013","unstructured":"Chintea CL, Belal M. Is there enough evidence for the use of intravesical instillations of glycosaminoglycan analogues in interstitial cystitis? BJU Inj. 2013;111(2):192\u20133.","journal-title":"BJU Inj"},{"issue":"6","key":"504_CR12","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1016\/j.urology.2012.01.059","volume":"79","author":"JC Nickel","year":"2012","unstructured":"Nickel JC, Hanno P, Kumar K, Thomas H. Second multicenter, randomized, double-blind, parallel-group evaluation of effectiveness and safety of intravesical sodium chondroitin sulfate compared with inactive vehicle control in subjects with interstitial cystitis\/bladder pain syndrome. Urology. 2012;79(6):1220\u20134.","journal-title":"Urology"},{"issue":"4","key":"504_CR13","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1016\/j.juro.2009.06.024","volume":"182","author":"YC Chuang","year":"2009","unstructured":"Chuang YC, Lee WC, Chiang PH. Intravesical liposome versus oral pentosan polysulfate for interstitial cystitis\/painful bladder syndrome. J Urol. 2009;182(4):1393\u2013400.","journal-title":"J Urol"},{"issue":"2","key":"504_CR14","first-page":"145","volume":"2","author":"EB Lander","year":"2014","unstructured":"Lander EB, See JR. Intravesical instillation of pentosan polysuflate encapsulated in a liposome nanocarrier for interstitial cystitis. Am J Clin Exp Urol. 2014;2(2):145\u20138.","journal-title":"Am J Clin Exp Urol"},{"key":"504_CR15","doi-asserted-by":"crossref","unstructured":"Wilkinson D and Erickson DR. Urinary and serologic markers for interstitial cystitis: an update. Curr Urol Rep. 2006;7(5):414\u201322.","DOI":"10.1007\/s11934-006-0013-1"},{"issue":"3","key":"504_CR16","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/S0090-4295(01)01586-2","volume":"59","author":"CL Parsons","year":"2002","unstructured":"Parsons CL, Forrest J, Nickel JC, Evans R, Lloyd LK, Barkin J, Mosbaugh PG, Kaufman DM, Hernandez-Graulau JM, Atkinson L, Albrecht D. Effect of pentosan polysulfate therapy on intravesical potassium sensitivity. Urology. 2002;59(3):329\u201333.","journal-title":"Urology"},{"issue":"7","key":"504_CR17","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1111\/j.1464-410X.2005.05776.x","volume":"96","author":"SK Gupta","year":"2005","unstructured":"Gupta SK, Pidcock L, Parr NJ. The potassium sensitivity test: a predictor of treatment response in interstitial cystitis. BJU. 2005;96(7):1063\u20136.","journal-title":"BJU"},{"key":"504_CR18","first-page":"86543","volume":"2014","author":"SK Keay","year":"2014","unstructured":"Keay SK, Birder LA, Chai TC. Evidence for bladder urothelial pathophysiology in functional bladder disorders. Biomed Res Int. 2014;2014:86543.","journal-title":"Biomed Res Int."},{"issue":"4","key":"504_CR19","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1016\/j.juro.2012.06.023","volume":"188","author":"JB Forrest","year":"2012","unstructured":"Forrest JB, Payne CK, Erickson DR. Cyclosporine A for refractory interstitial cystitis\/bladder pain syndrome: experience of 3 tertiary centers. J Urol. 2012;188(4):1186\u201391.","journal-title":"J Urol."},{"issue":"3","key":"504_CR20","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1097\/01.ju.0000153612.14639.19","volume":"173","author":"F Soucy","year":"2005","unstructured":"Soucy F, Gregoire M. Efficacy of prednisone for severe refractory ulcerative interstitial cystitis. J Urol. 2005;173(3):841\u20133.","journal-title":"J Urol."},{"issue":"6 Pt 1","key":"504_CR21","doi-asserted-by":"crossref","first-page":"2261","DOI":"10.1097\/01.ju.0000144761.69398.be","volume":"172","author":"A Hosseini","year":"2004","unstructured":"Hosseini A, Ehren I, Wiklund NP. Nitric oxide as an objective marker for evaluation of treatment response in patients with classic interstitial cystitis. J Urol. 2004;172(6 Pt 1):2261\u20135.","journal-title":"J Urol."},{"issue":"1","key":"504_CR22","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/S0090-4295(02)02077-0","volume":"61","author":"S Cetinel","year":"2003","unstructured":"Cetinel S, Cetinel BI, Ercan F, Hrda C, San T. Indomethacin-induced morphologic changes in the rat urinary bladder epithelium. Urology. 2003;61(1):236\u201342.","journal-title":"Urology."},{"issue":"6","key":"504_CR23","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1080\/003655999750017103","volume":"33","author":"J Schou","year":"1999","unstructured":"Schou J, Jensen HL, Frimodt-Moller C. Interstitial cystitis provoked by tiaprofenic acid. Scand J Urol Nephrol. 1999;33(6):411\u20132.","journal-title":"Scand J Urol Nephrol."},{"issue":"1","key":"504_CR24","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/S0094-0143(21)00590-5","volume":"21","author":"GR Sant","year":"1994","unstructured":"Sant GR, Theoharides TC. The role of the mast cell in interstitial cystitis. Urol Clin North Am. 1994;21(1):41\u201353.","journal-title":"Urol Clin North Am."},{"issue":"6","key":"504_CR25","doi-asserted-by":"crossref","first-page":"471","DOI":"10.3109\/00365590903199007","volume":"43","author":"JJ Wyndaele","year":"2009","unstructured":"Wyndaele JJ, Van Dyck J, Toussaint N. Cystoscopy and bladder biopsies in patients with bladder pain syndrome carried out following ESSIC guidelines. Scand J Urol Nephrol. 2009;43(6):471\u20135.","journal-title":"Scand J Urol Nephrol."},{"issue":"3","key":"504_CR26","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.mehy.2014.06.004","volume":"83","author":"F Aa Van der","year":"2014","unstructured":"Van der Aa F, Beckley I, de Ridder D. Polyomavirus BK: a potential new therapeutic target for painful bladder syndrome\/interstitial cystitis? Med Hypotheses. 2014;83(3):317\u201320.","journal-title":"Med Hypotheses."},{"issue":"5","key":"504_CR27","doi-asserted-by":"crossref","first-page":"1850","DOI":"10.1016\/j.juro.2008.01.047","volume":"179","author":"DR Erickson","year":"2008","unstructured":"Erickson DR, Tomaszewski JE, Kunselman AR, Setter CM, Peters KM, Rovner ES, Demers LM, Wheeler MA, Keay SK. Urine markers do not predict biopsy findings or presence of bladder ulcers in interstitial cystitis\/painful bladder syndrome. J Urol. 2008;179(5):1850\u20136.","journal-title":"J Urol."},{"issue":"Suppl 1","key":"504_CR28","first-page":"34","volume":"21","author":"HC Kuo","year":"2014","unstructured":"Kuo HC. Potential urine and serum biomarkers for patients with bladder pain syndrome\/interstitial cystitis. Int J Urol. 2014;21(Suppl 1):34\u201341.","journal-title":"Int J Urol."},{"issue":"5","key":"504_CR29","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1016\/j.urology.2015.01.021","volume":"85","author":"RA Henry","year":"2015","unstructured":"Henry RA, Morales A, Cahill CM. Beyond a simple anesthetic effect: lidocaine in the diagnosis and treatment of interstitial cystitis\/bladder pain syndrome. Urology. 2015;85(5):1025\u201333.","journal-title":"Urology."},{"issue":"3","key":"504_CR30","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1046\/j.1464-410x.2001.02031.x","volume":"87","author":"R Thilagarajah","year":"2001","unstructured":"Thilagarajah R, Witherow RO, Walker MM. Oral cimetidine gives effective symptom relief in painful bladder disease: a prospective, randomized, double-blind placebo-controlled trial. BJU Int. 2001;87(3):207\u201312.","journal-title":"BJU Int."},{"key":"504_CR31","doi-asserted-by":"crossref","unstructured":"Chiang G, Patra P, Letourneau R, Jeudy S, Boucher W, Green M, Sant GR, Theoharides TC. Pentosanpolysulfate (Elmiron) is a potent inhibitor of mast cell histamine secretion. Adv Exp Med Biol. 2003;539(Pt B):713\u201329.","DOI":"10.1007\/978-1-4419-8889-8_44"},{"issue":"1","key":"504_CR32","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1111\/j.1464-410X.1986.tb05433.x","volume":"58","author":"L Edwards","year":"1986","unstructured":"Edwards L, Bucknall TE, Makin C. Interstitial cystitis: possible cause and clinical study of sodium cromoglycate. Br J Urol. 1986;58(1):95\u20136.","journal-title":"Br J Urol."},{"key":"504_CR33","doi-asserted-by":"crossref","unstructured":"Theoharides TC, Sant GR. A pilot open label study of cystoprotek in interstitial cystitis. Int J Immunopathol Pharmacol. 2005;18(1):183\u20138.","DOI":"10.1177\/039463200501800119"},{"key":"504_CR34","doi-asserted-by":"crossref","unstructured":"Kuo HC, Jiang YH, Tsai YC, Kuo YC. Intravesical botulinum toxin-A injections reduce bladder pain of interstitial cystitis\/bladder pain syndrome refractory to conventional treatment: a prospective, multicenter, randomized, double-blind, placebo-controlled clinical trial. Neurourol Urodyn. 2015. doi: 10.1002\/nau.22760 [Epub ahead of print].","DOI":"10.1002\/nau.22760"},{"issue":"7","key":"504_CR35","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1002\/nau.20200","volume":"24","author":"EE Cole","year":"2005","unstructured":"Cole EE, Scarpero HM, Dmochowski RR. Are patient symptoms predictive of the diagnostic and\/or therapeutic value of hydrodistention? Neurourol Urodyn. 2005;24(7):638\u201342.","journal-title":"Neurourol Urodyn."},{"issue":"5","key":"504_CR36","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1016\/S0090-4295(94)80199-1","volume":"44","author":"DR Erickson","year":"1994","unstructured":"Erickson DR, Simon LJ, Belchis DA. Relationships between bladder inflammation and other clinical features in interstitial cystitis. Urology. 1994;44(5):655\u20139.","journal-title":"Urology."},{"key":"504_CR37","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1097\/00000478-199010000-00011","volume":"14","author":"WL Lynes","year":"1990","unstructured":"Lynes WL, Flynn SD, Shortliffe LD, Stamey TA. The histology of interstitial cystitis. Am J Surg Path. 1990;14:969.","journal-title":"Am J Surg Path."},{"issue":"4","key":"504_CR38","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1016\/S0022-5347(17)36844-1","volume":"148","author":"SK Yun","year":"1992","unstructured":"Yun SK, Laub DJ, Weese DL, Lad PM, Leach GE, Zimmern PE. Stimulated release of urine histamine in interstitial cystitis. J Urol. 1992;148(4):1145\u20138.","journal-title":"J Urol."},{"issue":"2","key":"504_CR39","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1016\/j.juro.2006.09.029","volume":"177","author":"DR Erickson","year":"2007","unstructured":"Erickson DR, Kunselman AR, Bentley CM, Peters KM, Rovner ES, Demers LM, Wheeler MA, Keay SK. Changes in urine markers and symptoms after bladder distention for interstitial cystitis. J Urol. 2007;177(2):556\u201360.","journal-title":"J Urol."},{"issue":"2","key":"504_CR40","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1046\/j.1464-410X.1998.00507.x","volume":"81","author":"JE Marchand","year":"1998","unstructured":"Marchand JE, Sant GR, Kream RM. Increased expression of substance P receptor-encoding mRNA in bladder biopsies from patients with interstitial cystitis. Br J Urol. 1998;81(2):224\u20138.","journal-title":"Br J Urol."},{"issue":"1","key":"504_CR41","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.juro.2015.02.082","volume":"194","author":"MA Farmer","year":"2015","unstructured":"Farmer MA, Huang L, Martucci K, Yang CC, Maravilla KR, Harris RE, Clauw DJ, Mackey S, Ellingson BM, Mayer EA, Schaeffer AJ, Apkarian AV, MAPP Research Network. Brain white matter abnormalities in female interstitial cystitis\/bladder pain syndrome: a MAPP network neuroimaging study. J Urol. 2015;194(1):118\u201326.","journal-title":"J Urol."},{"issue":"3","key":"504_CR42","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1016\/j.juro.2014.03.093","volume":"192","author":"LA Kilpatrick","year":"2014","unstructured":"Kilpatrick LA, Kutch JJ, Tillisch K, Naliboff BD, Labus JS, Jiang Z, Farmer MA, Apkarian AV, Mackey S, Martucci KT, Clauw DJ, Harris RE, Deutsch G, Ness TJ, Yang CC, Maravilla K, Mullins C, Mayer EA. Alterations in resting state oscillations and connectivity in sensory and motor networks in women with interstitial cystitis\/painful bladder syndrome. J Urol. 2014;192(3):947\u201355.","journal-title":"J Urol."},{"issue":"2","key":"504_CR43","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/j.juro.2013.08.024","volume":"191","author":"TJ Ness","year":"2014","unstructured":"Ness TJ, Lloyd LK, Fillingim RB. An endogenous pain control system is altered in subjects with interstitial cystitis. J Urol. 2014;191(2):364\u201370.","journal-title":"J Urol."},{"issue":"4","key":"504_CR44","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1016\/j.mayocp.2015.01.018","volume":"90","author":"I Gilron","year":"2015","unstructured":"Gilron I, Baron R, Jensen T. Neuropathic pain: principles of diagnosis and treatment. Mayo Clin Proc. 2015;90(4):532\u201345.","journal-title":"Mayo Clin Proc."},{"issue":"5","key":"504_CR45","doi-asserted-by":"crossref","first-page":"1853","DOI":"10.1016\/j.juro.2009.12.106","volume":"183","author":"HE Foster Jr","year":"2010","unstructured":"Foster HE Jr, Hanno PM, Nickel JC, Payne CK, Mayer RD, Burks DA, Yang CC, Chai TC, Kreder KJ, Peters KM, Lukacz ES, FitzGerald MP, Cen L, Landis JR, Propert KJ, Yang W, Kusek JW, Nyberg LM, Interstitial Cystitis Collaborative Research Network. Effect of amitriptyline on symptoms in treatment na\u00efve patients with interstitial cystitis\/painful bladder syndrome. J Urol. 2010;183(5):1853\u20138.","journal-title":"J Urol."},{"issue":"2","key":"504_CR46","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1097\/01.ju.0000132388.54703.4d","volume":"172","author":"A Ophoven van","year":"2004","unstructured":"van Ophoven A, Pokupic S, Heinecke A, Hertle L. A prospective, randomized, placebo controlled, double-blind study of amitriptyline for the treatment of interstitial cystitis. J Urol. 2004;172(2):533\u20136.","journal-title":"J Urol."},{"issue":"2","key":"504_CR47","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1016\/j.juro.2006.09.055","volume":"177","author":"A Ophoven van","year":"2007","unstructured":"van Ophoven A, Hertle L. The dual serotonin and noradrenaline reuptake inhibitor duloxetine for the treatment of interstitial cystitis: results of an observational study. J Urol. 2007;177(2):552\u20135.","journal-title":"J Urol."},{"key":"504_CR48","doi-asserted-by":"crossref","unstructured":"Moulin D, Boulanger A, Clark AJ, Clarke H, Dao T, Finley GA, Furlan A, Gilron I, Gordon A, Morley-Forster PK, Sessle BJ, Squire P, Stinson J, Taenzer P, Velly A, Ware MA, Weinberg EL, Williamson OD. Pharmacological management of chronic neuropathic pain: revised consensus statement from the Canadian Pain Society. Pain Res Manag. 2014;19(6):328\u201335.","DOI":"10.1155\/2014\/754693"},{"issue":"7","key":"504_CR49","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1111\/bju.12266","volume":"112","author":"VM Collins","year":"2013","unstructured":"Collins VM, Daly DM, Liaskos M, McKay NG, Sellers D, Chapple C, Grundy D. OnabotulinumtoxinA significantly attenuates bladder afferent nerve firing and inhibits ATP release from the urothelium. BJU Int. 2013;112(7):1018\u201326.","journal-title":"BJU Int."},{"issue":"5","key":"504_CR50","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1111\/j.1464-410X.2009.08495.x","volume":"104","author":"HC Kuo","year":"2009","unstructured":"Kuo HC, Chancellor MB. Comparison of intravesical botulinum toxin type A injections plus hydrodistention with hydrodistention alone for the treatment of refractory interstitial cystitis\/painful bladder syndrome. BJU Int. 2009;104(5):657\u201361.","journal-title":"BJU Int."},{"issue":"1","key":"504_CR51","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1002\/nau.22438","volume":"33","author":"CD Cruz","year":"2014","unstructured":"Cruz CD. Neurotrophins in bladder function: what do we know and where do we go from here? Neurourol Urodyn. 2014;33(1):39\u201345.","journal-title":"Neurourol Urodyn."},{"issue":"3","key":"504_CR52","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1111\/jnc.12093","volume":"124","author":"L McKlevey","year":"2013","unstructured":"McKlevey L, Shorten GD, O\u2019Keefe GW. Nerve growth factor-mediated regulation of pain signaling and proposed new intervention strategies in clinical pain management. J Neurochem. 2013;124(3):276\u201389.","journal-title":"J Neurochem."},{"issue":"4","key":"504_CR53","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1046\/j.1464-410X.1997.00097.x","volume":"79","author":"EM Lowe","year":"1997","unstructured":"Lowe EM, Anand P, Terenghi G, Williams-Chestnut RE, Sinicropi DV, Osborne JL. Increased nerve growth factor levels in the urinary bladder of women with idiopathic sensory urgency and interstitial cystitis. Br J Urol. 1997;79(4):572\u20137.","journal-title":"Br J Urol."},{"issue":"3","key":"504_CR54","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/j.urology.2007.04.038","volume":"70","author":"HT Liu","year":"2007","unstructured":"Liu HT, Kuo HC. Intravesical botulinum toxin A injections plus hydrodistension can reduce nerve growth factor production and control bladder pain in interstitial cystitis. Urology. 2007;70(3):463\u20138.","journal-title":"Urology."},{"issue":"2","key":"504_CR55","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1159\/000355175","volume":"92","author":"BL Liu","year":"2014","unstructured":"Liu BL, Yang F, Zhan HL, Feng ZY, Zhang ZG, Li WB, Zhou XF. Increased severity of inflammation correlates with elevated expression of TRPV1 nerve fibers and nerve growth factor on interstitial cystitis\/bladder pain syndrome. Urol Int. 2014;92(2):202\u20138.","journal-title":"Urol Int."},{"issue":"9","key":"504_CR56","doi-asserted-by":"crossref","first-page":"e106321","DOI":"10.1371\/journal.pone.0106321","volume":"9","author":"HC Qu","year":"2014","unstructured":"Qu HC, Zhang W, Yan S, Liu YL, Wang P. Urinary nerve growth factor could be a biomarker for interstitial cystitis\/painful bladder syndrome: a meta-analysis. PLoS One. 2014;9(9):e106321.","journal-title":"PLoS One."},{"issue":"1","key":"504_CR57","first-page":"4989","volume":"17","author":"BL Jacobs","year":"2010","unstructured":"Jacobs BL, Smaldone MC, Tyagi V, Phillips BJ, Jackman SV, Leng WW, Tyagi P. Increased nerve growth factor in neurogenic overactive bladder and interstitial cystitis patients. Can J Urol. 2010;17(1):4989\u201394.","journal-title":"Can J Urol."},{"key":"504_CR58","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1111\/j.1757-5672.2010.00065.x","volume":"2","author":"HC Kuo","year":"2010","unstructured":"Kuo HC, Liu HT, Tyagi P, Chancellor M. Urinary nerve growth factor levels in urinary Tract disease with or without frequency urgency symptoms. LUTS. 2010;2:88\u201394.","journal-title":"LUTS."},{"key":"504_CR59","doi-asserted-by":"crossref","unstructured":"Gamper M, Moser R, Viereck V. Have we been led astray by the NGF biomarker data? Neurourol Urodyn. 2015. doi: 10.1002\/nau.22882 [Epub ahead of print].","DOI":"10.1002\/nau.22882"},{"issue":"12","key":"504_CR60","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1186\/1471-2180-12-205","volume":"13","author":"H Siddiqui","year":"2012","unstructured":"Siddiqui H, Lagesen K, Nederbragt AJ, Jeansson SL, Jakobsen KS. Alterations of microbiota in urine from women with interstitial cystitis. BMC Microbiol. 2012;13(12):205.","journal-title":"BMC Microbiol."},{"issue":"9","key":"504_CR61","doi-asserted-by":"crossref","first-page":"e0137310","DOI":"10.1371\/journal.pone.0137310","volume":"10","author":"BJ Winter","year":"2015","unstructured":"Winter BJ, O\u2019Connell HE, Bowden S, Carey M, Eisen DP. A case control study reveals that polyomaviruria is significantly associated with interstitial cystitis and vesical ulceration. PLoS One. 2015;10(9):e0137310.","journal-title":"PLoS One."},{"issue":"Suppl 1","key":"504_CR62","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1111\/iju.12308","volume":"21","author":"N Yoshimura","year":"2014","unstructured":"Yoshimura N, Oguchi T, Yokoyama H, Funahashi Y, Yoshikawa S, Sugino Y, Kawamorita N, Kashyap MP, Chancellor MB, Tyagi P, Ogawa T. Bladder afferent hyperexcitability in bladder pain syndrome\/interstitial cystitis. Int J Urol. 2014;21(Suppl 1):18\u201325.","journal-title":"Int J Urol."}],"container-title":["Drugs"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40265-015-0504-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s40265-015-0504-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40265-015-0504-9","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,12]],"date-time":"2024-06-12T13:06:47Z","timestamp":1718197607000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s40265-015-0504-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,11,24]]},"references-count":62,"journal-issue":{"issue":"18","published-print":{"date-parts":[[2015,12]]}},"alternative-id":["504"],"URL":"https:\/\/doi.org\/10.1007\/s40265-015-0504-9","relation":{},"ISSN":["0012-6667","1179-1950"],"issn-type":[{"value":"0012-6667","type":"print"},{"value":"1179-1950","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,11,24]]}}}